A Study of KIVU-107 in Participants With Locally Advanced or Metastatic Solid Tumors
Kivu Bioscience Inc.
Kivu Bioscience Inc.
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Icahn School of Medicine at Mount Sinai
National Cancer Institute (NCI)
Ohio State University Comprehensive Cancer Center
National Cancer Institute (NCI)
University of Wisconsin, Madison
Eli Lilly and Company
TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)
ALX Oncology Inc.
National Cancer Institute (NCI)
Beijing Biotech
BriaCell Therapeutics Corporation
Beijing Biotech
Rutgers, The State University of New Jersey
Actuate Therapeutics Inc.
Conjupro Biotherapeutics, Inc.
NRG Oncology
Peter MacCallum Cancer Centre, Australia
Incyclix Bio
AstraZeneca
Memorial Sloan Kettering Cancer Center
Vanderbilt-Ingram Cancer Center
Eli Lilly and Company
National Cancer Institute (NCI)
GlaxoSmithKline
Institut Paoli-Calmettes
Orano Med LLC
Eli Lilly and Company
Eli Lilly and Company
Beijing Biotech
M.D. Anderson Cancer Center
AstraZeneca
All India Institute of Medical Sciences, Bhubaneswar
Stanford University
Centre Oscar Lambret
M.D. Anderson Cancer Center
The Methodist Hospital Research Institute
PMV Pharmaceuticals, Inc
Mayo Clinic
Tomsk National Research Medical Center of the Russian Academy of Sciences
Merck Sharp & Dohme LLC
Ambrx, Inc.
Alterome Therapeutics, Inc.
Baptist Health South Florida
Dana-Farber Cancer Institute
ViroMissile, Inc.
Eli Lilly and Company